Friday, May 12, 2017

Inosine treatment can help restore motor control after cortical injury

›
Brain tissue can die as the result of stroke, traumatic brain injury, or neurodegenerative disease. When the affected area includes the mo...
Thursday, May 11, 2017

New drug could help decrease symptoms of asthma

›
"This new drug could be a game changer for future treatment of asthma" - Professor Chris Brightling, NIHR Senior Research Fellow...
Wednesday, May 10, 2017

New Antibiotic Discovered in the Nose

›
German researchers analyzed germs that inhabit the human body and found that about 30 percent of people had  Staphylococcus aureus  bacter...
Tuesday, May 9, 2017

FDA Approves First Generic Version of Widely Used Influenza Drug Tamiflu

›
In continuation of my update on tamiflu  oseltamivir  phosphate U.S. Food and Drug Administration approved the first generic version of ...
Monday, May 8, 2017

FDA Approves Flonase Sensimist Allergy Relief

›
In continuation of my update on  fluticasone GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA...

FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older

›
We know that,   Lisinopril   is a drug of the   angiotensin-converting enzyme (ACE) inhibitor   class used primarily in treatment of   hig...
Thursday, May 4, 2017

Lisinopril oral solution approved for treatment of hypertension in children and adults

›
Silvergate Pharmaceuticals, Inc.  leader in the development and commercialization of innovative and safe medicines for children, today ann...

Lisinopril oral solution approved for treatment of hypertension in children and adults

›
Silvergate Pharmaceuticals, Inc.  leader in the development and commercialization of innovative and safe medicines for children, today ann...
Wednesday, May 3, 2017

FDA Expands Indication For Type 2 Diabetes Treatment Synjardy (Empagliflozin/Metformin Hydrochloride) To Include Treatment-Naïve Adults

›
In continuation of my update on empagliflozin  and metformin The U.S. Food and Drug Administration has approved an expanded indication...
2 comments:
Tuesday, May 2, 2017

Sanofi Receives FDA Approval of Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes

›
Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Adlyxin ( lixisenatide) , a once-daily mealtime GLP-1 rec...

AbbVie Receives U.S. FDA Approval of Once-Daily Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C

›
In continuation of my update on  Dasabuvir ,    ombitasvir , paritaprevir  and ritonavir   AbbVie (NYSE: ABBV), a global biopharmaceut...
Monday, May 1, 2017

Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of Belviq XR (lorcaserin HCl) Extended-Release Tablets

›
In continuation of my update on Lorcaserin Eisai Inc. and Arena Pharmaceuticals, Inc.   announced   the approval by  U.S. Food and Drug ...
Sunday, April 30, 2017

New wonder compound offers strong protection against harmful effects of UVA rays

›
A new wonder compound developed by University of Bath scientists in collaboration with King's College London offers unprecedented prot...
Saturday, April 29, 2017

Combinations of three antibiotics could help combat drug-resistant bacterial infections

›
Each year, approximately 700,000 people die from drug-resistant bacterial infections. A study by UCLA life scientists could be a major ...
Friday, April 28, 2017

Combination of two plant compounds holds promise in treating colon cancer

›
In combination of my update on curcumin The combination of two plant compounds that have medicinal properties - curcumin and silymarin...